ArticleBiomarker insights2022

Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer.

Wan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.